Do you want to read an article? Please log in or register.
Longer-term outcomes in offspring of GDM mothers treated with metformin versus insulin
Diabetes - GeneralDiabetes and Pregnancy
COMMENTED
Related content
Diabetes and Pregnancy
Association of Long-term Child Growth and Developmental Outcomes With Metformin vs Insulin Treatment for Gestational Diabetes
JAMA Pediatr.
Landi SN, Radke S, Engel SM, Boggess K, Stürmer T, Howe AS, Funk MJ
doi: 10.1001/jamapediatrics.
COMMENTED
Diabetes - General
Metformin versus insulin therapy for gestational diabetes: Effects on offspring anthropometrics and metabolism at the age of 9 years-A follow-up study of two open-label, randomised, controlled trials
★ 2
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
Diabetes Obes Metab
Paavilainen E, Tertti K, Nikkinen H, Veijola R, Vääräsmäki M, Loo BM, Tossavainen P, Rönnemaa T, Niinikoski H
doi: 10.1111/dom.14589
Diabetes and Pregnancy
Follow-up at 1 year and beyond of women with gestational diabetes treated with insulin and/or oral glucose-lowering agents: a core outcome set using a Delphi survey
Diabetologia.
Bogdanet D, Reddin C, Macken E, Griffin TP, Fhelelboom N, Biesty L, Thangaratinam S, Dempsey E, Crowther C, Galjaard S, Maresh M, Loeken MR, Napoli A, Anastasiou E, Noctor E, de Valk HW, van Poppel MNM, Agostini A, Clarson C, Egan AM, O'Shea PM, Devane D, Dunne FP
doi: 10.1007/s00125-019-4935-9.
Diabetes - GeneralDiabetes and Pregnancy
Amino Acid Profile in Women with Gestational Diabetes Mellitus Treated with Metformin or Insulin
Diabetes Res Clin Pract.
Huhtala MS, Tertti K, Pellonperä O, Rönnemaa T
doi: 10.1016/
Diabetes - GeneralType 2 DiabetesGlycemic Control
Efficacy and safety of once-weekly semaglutide versus once-daily insulin glargine as add-on to metformin (with or without sulfonylureas) in insulin-naive patients with type 2 diabetes (SUSTAIN 4): a randomised, open-label, parallel-group, multicentre, multinational, phase 3a trial
Lancet Diabetes Endocrinol.
Aroda VR, Bain SC, Cariou B, Piletič M, Rose L, Axelsen M, Rowe E, DeVries JH
doi: 10.1016/S2213-8587(17)
Type 2 Diabetes
Risk of hypoglycaemia with insulin degludec versus insulin glargine U300 in insulin-treated patients with type 2 diabetes: the randomised, head-to-head CONCLUDE trial
Diabetologia.
Philis-Tsimikas A, Klonoff DC, Khunti K, Bajaj HS, Leiter LA, Hansen MV, Troelsen LN, Ladelund S, Heller S, Pieber TR, CONCLUDE Study Group.
doi: 10.1007/s00125-019-05080-9.
Diabetes - General
Effect of Long-term Metformin and Lifestyle in the Diabetes Prevention Program and its Outcome Study on Coronary Artery Calcium
Circulation.
Goldberg RB, Aroda VR, Bluemke DA, Barrett-Connor E, Budoff MJ, Crandall JP, Dabelea D, Horton ES, Mather KJ, Orchard TJ, Schade D, Watson K, Temprosa M; Diabetes Prevention Program Research Group
doi: 10.1161/CIRCULATIONAHA.
COMMENTED
Type 2 DiabetesGlycemic Control
A Randomized Trial Evaluating the Efficacy and Safety of Fast-Acting Insulin Aspart Compared With Insulin Aspart, Both in Combination With Insulin Degludec With or Without Metformin, in Adults With Type 2 Diabetes (Onset 9)
★ 1
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
doi: 10.2337/dc19-2232.
Type 2 Diabetes
Advancing therapy in suboptimally controlled basal insulin-treated type 2 diabetes: Clinical outcomes with iGlarLixi versus premix BIAsp 30 in the SoliMix randomized controlled trial
Diabetes Care
Rosenstock J, Emral R, Sauque-Reyna L, Mohan V, Trescolí C, Sifri SA, Lalic N, Alvarez A, Picard P, Bonnemaire M, Demil N, McCrimmon RJ, SoliMix Trial Investigators.
doi: 10.2337/dc21-0393